Consolidated revenue from operations was at Rs10.88cr in the quarter against Rs11.34cr in Q4FY19 and Rs12.07cr in Q3FY20.
Due to the temporary suspension of services of elective surgeries and travel restrictions of overseas patients, business operations of the Shalby is expected to be lower in the short term, though the same is not likely to have a continuing impact on the business of the company.
Post result announcement, Shalby stock ended down 1.72% at Rs65.85 per piece on Sensex.
The stock also touched an intraday high and low of Rs66.60 per piece and Rs64.65 per piece respectively.
Overall, in FY20, the company’s net profit and revenue stand at Rs27.5cr and Rs48.68cr compared to Rs31.6cr and Rs46.22cr of FY19.
